ALFAVISION S | EVOQ REMEDIES LTD. | ALFAVISION S/ EVOQ REMEDIES LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -14.6 | - | - | View Chart |
P/BV | x | 1.0 | 0.6 | 179.1% | View Chart |
Dividend Yield | % | 0.4 | 0.0 | - |
ALFAVISION S EVOQ REMEDIES LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ALFAVISION S Mar-23 |
EVOQ REMEDIES LTD. Mar-23 |
ALFAVISION S/ EVOQ REMEDIES LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 42 | 24 | 169.9% | |
Low | Rs | 10 | 11 | 90.8% | |
Sales per share (Unadj.) | Rs | 18.6 | 15.0 | 123.9% | |
Earnings per share (Unadj.) | Rs | -0.7 | 1.2 | -57.7% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 1.2 | -56.2% | |
Dividends per share (Unadj.) | Rs | 0.05 | 0 | - | |
Avg Dividend yield | % | 0.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 13.7 | 18.2 | 75.3% | |
Shares outstanding (eoy) | m | 31.53 | 13.60 | 231.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 1.2 | 117.3% | |
Avg P/E ratio | x | -37.6 | 14.9 | -252.1% | |
P/CF ratio (eoy) | x | -38.4 | 14.9 | -258.5% | |
Price / Book Value ratio | x | 1.9 | 1.0 | 193.0% | |
Dividend payout | % | -7.3 | 0 | - | |
Avg Mkt Cap | Rs m | 813 | 241 | 337.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 2 | 47.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 586 | 204 | 287.3% | |
Other income | Rs m | 0 | 60 | 0.1% | |
Total revenues | Rs m | 586 | 264 | 221.8% | |
Gross profit | Rs m | 27 | -37 | -71.2% | |
Depreciation | Rs m | 0 | 0 | 1,225.0% | |
Interest | Rs m | 48 | 0 | 476,700.0% | |
Profit before tax | Rs m | -22 | 23 | -94.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 7 | 1.8% | |
Profit after tax | Rs m | -22 | 16 | -133.7% | |
Gross profit margin | % | 4.5 | -18.3 | -24.8% | |
Effective tax rate | % | -0.5 | 29.1 | -1.9% | |
Net profit margin | % | -3.7 | 7.9 | -46.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 542 | 349 | 155.2% | |
Current liabilities | Rs m | 50 | 101 | 49.9% | |
Net working cap to sales | % | 83.8 | 121.5 | 69.0% | |
Current ratio | x | 10.7 | 3.4 | 311.1% | |
Inventory Days | Days | 749 | 0 | - | |
Debtors Days | Days | 3,041 | 3,082 | 98.7% | |
Net fixed assets | Rs m | 1,507 | 0 | 1,674,333.3% | |
Share capital | Rs m | 62 | 136 | 45.5% | |
"Free" reserves | Rs m | 371 | 112 | 331.5% | |
Net worth | Rs m | 433 | 248 | 174.6% | |
Long term debt | Rs m | 1,565 | 0 | - | |
Total assets | Rs m | 2,048 | 349 | 586.9% | |
Interest coverage | x | 0.5 | 2,286.0 | 0.0% | |
Debt to equity ratio | x | 3.6 | 0 | - | |
Sales to assets ratio | x | 0.3 | 0.6 | 48.9% | |
Return on assets | % | 1.3 | 4.6 | 27.4% | |
Return on equity | % | -5.0 | 6.5 | -76.6% | |
Return on capital | % | 1.3 | 9.2 | 14.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 26 | -43 | -58.7% | |
From Investments | Rs m | -160 | NA | 123,130.8% | |
From Financial Activity | Rs m | 127 | 14 | 894.1% | |
Net Cashflow | Rs m | -8 | -29 | 26.5% |
Indian Promoters | % | 24.8 | 20.5 | 120.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 75.2 | 79.5 | 94.6% | |
Shareholders | 2,884 | 1,672 | 172.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ALFAVISION S With: ADANI ENTERPRISES MMTC REDINGTON SIRCA PAINTS INDIA OPTIEMUS INFRACOM
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ALFAVISION S | EVOQ REMEDIES LTD. |
---|---|---|
1-Day | -0.28% | -0.10% |
1-Month | -4.59% | 10.77% |
1-Year | 16.46% | -21.42% |
3-Year CAGR | 54.52% | -23.84% |
5-Year CAGR | 33.80% | -15.08% |
* Compound Annual Growth Rate
Here are more details on the ALFAVISION S share price and the EVOQ REMEDIES LTD. share price.
Moving on to shareholding structures...
The promoters of ALFAVISION S hold a 24.8% stake in the company. In case of EVOQ REMEDIES LTD. the stake stands at 20.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALFAVISION S and the shareholding pattern of EVOQ REMEDIES LTD..
Finally, a word on dividends...
In the most recent financial year, ALFAVISION S paid a dividend of Rs 0.1 per share. This amounted to a Dividend Payout ratio of -7.3%.
EVOQ REMEDIES LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of ALFAVISION S, and the dividend history of EVOQ REMEDIES LTD..
For a sector overview, read our finance sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.